Literature DB >> 6108176

Subcellular fractionation studies of human rectal mucosa: localization of the mucosal peptide hormones.

J Dawson, M G Bryant, S R Bloom, T J Peters.   

Abstract

1. Analytical subcellular fractionation techniques have been applied to endoscopic human rectal biopsies to study the localization of enteroglucagon, somatostatin, vasoactive intestinal peptide and the properties of the principal subcellular organelles. 2. The peptide hormones, detected by radioimmunoassay, showed particulate localizations with single peaks in the density gradients for enteroglucagon (modal density 1.25) and somatostatin (modal density 1.23). Vasoactive intestinal peptide showed a less discrete localization but demonstrated a major peak (modal density, 1.17) with a small subsidiary peak (modal density 1.24). 3. The following organelles, characterized by their marker enzymes, were located in the density gradients; plasma membrane (5'-nucleotidase), mitochondria (malate dehydrogenase), peroxisomes (catalase), lysosomes (beta-N-acetyl-D-glucosaminidase), endoplasmic reticulum (neutral alpha-D-glucosidase) and cytosol (lactate dehydrogenase). 4. This technique can be used to investigate disease of the human rectum at a subcellular level.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6108176     DOI: 10.1042/cs0590457

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  2 in total

1.  Hypertrophic cardiomyopathy in three generations of a large Norwegian family. A clinical, echocardiographic, and genetic study.

Authors:  H Haugland; O J Ohm; H Boman; E Thorsby
Journal:  Br Heart J       Date:  1986-02

2.  Mucosal transcriptomics implicates under expression of BRINP3 in the pathogenesis of ulcerative colitis.

Authors:  Philip J Smith; Adam P Levine; Jenny Dunne; Paul Guilhamon; Mark Turmaine; Gavin W Sewell; Nuala R OʼShea; Roser Vega; Jennifer C Paterson; Dahmane Oukrif; Stephan Beck; Stuart L Bloom; Marco Novelli; Manuel Rodriguez-Justo; Andrew M Smith; Anthony W Segal
Journal:  Inflamm Bowel Dis       Date:  2014-10       Impact factor: 5.325

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.